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ABSTRACT
Objective: To describe the original cystoprostatectomy technique which allows the preserva-
tion of sexual and urinary function in the majority of treated patients.
Surgical Technique: The described technique presents some details that distinguish it from
classic cystectomy: 1) a more efficient control of prostate venous and arterial tributaries; 2) preserva-
tion of prostatic capsule and enucleation of prostatic parenchyma, which is removed in block together
with the bladder, without violating the vesical neck; 3) no manipulation of the distal urethral sphinc-
teric complex; 4) preservation of seminal vesicles and maintenance of cavernous neurovascular bundles;
5) wide anastomosis between the ileal neobladder and the prostatic capsule.
Comments: The proposed maneuvers allow the performance of radical cystectomy with inte-
gral preservation of distal urethral sphincter and of cavernous neurovascular bundles, without jeopar-
dizing the oncological principles.
Key words: bladder; bladder neoplasms; cystectomy; urinary diversion; urinary reservoirs, continence
Int Braz J Urol.  2003; 29: 336-44
 Surgical Technique
International Braz J Urol
Official Journal of the Brazilian Society of Urology
Vol. 29 (4): 336-344, July - August, 2003
INTRODUCTION
Patients who have an invasive bladder can-
cer, stages T2-T4, are currently treated with radical
surgery, radiotherapy, chemotherapy or with a com-
bination of these approaches (1). According to avail-
able data, radical cystectomy with urinary reconstruc-
tion represents the most effective way for treating such
cases, accompanied by cure rates that oscillate be-
tween 53% to 80%, when there is no regional or sys-
temic extension of the disease (1).
Despite its therapeutic advantages, radical
cystectomy represents a major intervention, accom-
panied by morbidity rates that should not be disre-
garded. In addition to the inherent post-operative com-
plications, radical cystectomy presented, in the past,
2 serious drawbacks. Until the final 80s, most of these
patients underwent an incontinent cutaneous urinary
diversion, which constrained them to bear urine-col-
lecting bags, with all the resultant psychological and
social drawbacks. Furthermore, almost all male pa-
tients developed erectile dysfunction, which compro-
mised their quality of life.
Upon the introduction of orthotopic intesti-
nal neobladders in the urologic practice (2) and the
description of the technique that allowed the preser-
vation of cavernous neurovascular bundles (3), the
drawbacks of cutaneous ostomies and sexual dysfunc-
tion were both mitigated, but they could not be to-
tally avoided. About 10% of patients treated in this
way maintain severe diurnal incontinence and almost
half of cases remain with nocturnal enuresis for ex-
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tended periods (4). On the other hand, even when
employing the technique for preserving the cavern-
ous bundles, only 50% of the treated patients evidence
penile erections post-operatively (5).
With the purpose of solving these problems,
Spitz et al. described in 1999 an alternative technique
of radical cystectomy that preserved sexual, ejacula-
tory, and urinary functions in treated patients (6).
Other studies were subsequently published with the
same scope (7,8,9) and all of them contemplated, in a
common way, maneuvers intended to maintain the
integrity of the distal urethral sphincteric complex,
responsible for urinary continence, and the cavern-
ous neurovascular bundles, implied in the sexual func-
tion. Despite the significant reduction in risks of uri-
nary incontinence and erectile dysfunction, these tech-
niques presented 2 shortcomings witnessed by us in
a small number of treated cases. The block transec-
tion of the prostate gland along with the vesical neck
is accompanied by a more marked bleeding that the
one observed when employing classical techniques
of radical cystectomy. For the same reason, preserva-
tion of the prostatic parenchyma, common to all such
new proposed techniques creates the risk of incom-
plete removal of vesical neoplasia, when it infiltrates
and outgrows the vesical neck. For these reasons, we
proposed a new technique of radical cystectomy that
aims to preserve the integrity of sexual and urinary
functions and that allows a greater control of intra-
operative bleeding and a more effective resection of
tumors located close to the vesical neck.
SURGICAL TECHNIQUE
With the patient under general anesthesia,
through a wide median abdominal incision, the blad-
der is separated from the abdomen anterior wall,
maintaining, together with the organ, the parietal peri-
toneum that covers it superiorly. A bilateral pelvic
lymphadenectomy is performed, removing the lymph
nodes located around the common, external and in-
ternal iliac vessels, and close to the obturator ves-
sels. Distal ureters in both sides are dissected and sec-
tioned close to the bladder.
Subsequently, the bladder is laterally released
from the pelvic wall and the vesicoprostatic segment
is anteriorly dissected up to the prostatic apex. The
preprostatic fat is removed, carefully controlling the
superficial branch of the deep dorsal vein of penis at
the level of the prostatic apex. The intervention pro-
ceeds with transection of lateral peritoneal wings,
which fix the vesical dome to the pelvic wall. Inside
these sheets, we found the vas deferens, and in a more
posterior location, the superior vesical arteries, all of
which are sectioned and ligated.
Upon releasing the bladder from the struc-
tures that involve it anteriorly, superiorly and later-
ally, the hemostatic control of arterial and venous
vessels that involve the prostate begins. Prostatic ar-
teries, located in the vesico-prostatic sulcus on each
side, are ligated with 2 large and deep “figure-of-8”
stitches, with vicryl zero, applied next to the origin
of such vessels in the inferior vesical arteries (Fig-
ure-1). Next, the 3 venous trunks, one medial and two
lateral, which run over the anterior prostate surface,
from the deep dorsal vein of penis, are controlled. To
accomplish this, 2 parallel and transversal rows of 3
zero vicryl stitches are applied; with the first row lo-
cated more distally, at about 1.5 cm from the vesical
neck, and other row more proximally, at 0.5 cm from
the neck (Figure-2). These stitches penetrate deeply
the prostate capsule and, once they are tied, they con-
trol the prostate ascending venous tributaries and the
bladder descending branches. They also enable the
control of arterial vessels that run in the prostatic cap-
sule. Before incising the prostatic capsule, a third row
of 3 zero vicryl stitches is done distally to the previ-
ous rows, and are not tied (Figure-2). The anterior
portion of the prostatic capsule is incised transversally
with an electrocautery, between the first 2 rows of
stitches previously tied, until the prostatic parenchyma
is reached. Through digital and scissors-aided dis-
section, the parenchyma is separated from the pros-
tatic capsule, in a maneuver similar to the one per-
formed when an adenoma is enucleated. The urethra
is sectioned distally, but the base of the prostate is
kept adhered to the vesical neck, forming a single
block with the bladder, whose lumen is not violated
(Figure-3). Upon the completion of the distal enucle-
ation of the prostate, the more distal capsular stitches
are tied and kept repaired. This maneuver allows the
definitive control of tributaries of the deep dorsal vein
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Figure 1 -  Double ligation of prostatic artery.
Figure 2 - Control of ascending and descending venous tribu-
taries.
Figure 3 - A) Anterior capsulotomy. B) Enucleation of the adenoma.
A B
of the penis, which often start to bleed in the
capsulotomy’s distal margin following the prostatic
enucleation. Such intercurrence results from the loos-
ening of the previously tied capsular stitches, due to
the enucleation of the adenoma.
At this moment, the anterior manipulation of
prostate and bladder is interrupted and the posterior
dissection of the block is proceeded. In order to cre-
ate a correct plane between the bladder and the semi-
nal vesicles, which will be preserved, we repaired the
vas deferens in both sides at the posterosuperior sur-
face of the bladder. Through digital and scissors-aided
dissection, the surgeon advances in caudal direction
between the bladder and the vas deferens, and then
anteriorly to the seminal vesicles, until the prostatic
base is reached (Figure-4). Resuming the anterior dis-
section of the specimen and maintaining a small
sponge between the bladder and the seminal vesicles,
the capsulotomy is completed in its posterior half,
with a special precaution to avoid damage to the cav-
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Figure 4 - Detachment of  posterior surface  of the prostate. Figure 5 - Release of bladder-adenoma block, following poste-
rior capsulotomy.
Figure 6 - Anastomosis between the neobladder and the pros-
tatic capsule.
ernous neurovascular bundles (Figure-5). These ma-
neuvers culminate with the complete release of the
bladder-prostatic adenoma block, which will be re-
moved, and the distal prostatic capsule, preserved.
Samples of tissue from the  distal margin of the cap-
sule are removed and submitted to freezing patho-
logic study in order to confirm the absence of residual
neoplasia.
Cystectomy is completed sectioning the 2
lateral vesical pedicles, performed with the aid of
Mixter forceps or hemoclamps applied in
craniocaudal direction. The specimen formed by the
bladder connected to prostatic adenoma is removed,
the prostatic cavity and the capsular margins are re-
vised and small bleeding vessels are controlled with
electrocautery or with “figure-of-8” 3-zero vicryl
stitches.
The intervention proceeds with the construc-
tion of an orthotopic ileal neobladder, for which we
use Camey II or Studer techniques (2,10). Once the
neobladder is done and double-J catheters are inserted
in both ureters, the anastomosis between the
neobladder and the remaining distal prostatic capsule
is performed (Figure-6). This anastomosis is made
with a continuous 2-zero vicryl suture, and before its
completion a 20F Foley urethral catheter is placed in
the neobladder, and the distal ends of both double-J
catheters are tied to it.
Surgery is finished with the installation of
continuous suction drains at the level of the anasto-
mosis between the neobladder and the prostate and
near the sites of ureteral implantation. These drains
are maintained until the 7th post-operative day and
the Foley catheter, tied to the double-J catheters, are
removed on the 20th day after the intervention.
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COMMENTS
In this work we present an original alterna-
tive technique for radical cystectomy, which allows
integral preservation of urinary continence and re-
duces substantially the risks of sexual impotence. In
an initial group of 6 treated patients, 5 presented com-
plete diurnal and nocturnal continence immediately
after removing the urethral catheter, 3 referred penile
erections on the first month and none evidenced posi-
tive surgical margins at the level of vesical neck or
prostatic parenchyma.
In contrast to the classical radical
cystoprostatectomy technique, this method preserves
the prostatic capsule, the cavernous neurovascular
bundles and is not accompanied by manipulation of
the distal urethral sphincteric complex. For such rea-
sons, this technique, which could be referred to as
cysto-adenomectomy, has a highly favorable impact
over the maintenance of urinary and sexual functions
post-operatively. Another advantage of this technique
is the fact that it is accompanied by a block removal
of bladder and prostatic parenchyma, reducing the
risks of incomplete removal of the vesical neoplasia,
when it invades the vesical neck and the prostate by
intraluminal direct extension.
Under a surgical perspective, this method in-
corporates maneuvers that allow a quite efficient con-
trol of the anterior periprostatic venous trunks and
the lateral prostatic arteries (11), significantly reduc-
ing intra-operative bleeding. As a matter of fact, none
of the 6 patients treated up to now, required blood
transfusions during or after surgery.
The only drawback of the cysto-
adenomectomy technique, compared with the classic
radical cystectomy, is that it does not remove a pros-
tate cancer when this tumor is coincidentally present
in addition to the vesical neoplasia (12). To minimize
this problem, the cysto-adenomectomy technique
must be indicated when the existence of a prostate
cancer is highly unlikely, that is, in patients with
medical examination and normal serum levels of pro-
static specific antigen or, in case of doubt, with nega-
tive pre-operative prostatic biopsy.
The first proposal about preservation of
sexual and ejaculatory function in radical cystectomy
was made in 1999 (6). These authors described a tech-
nique that removed the anterior half of the prostate
and preserved its posterior portion. After that, 3 more
studies were published with the same objective, all
of them proposing the preservation of the prostate
and bladder resection with distal transection of the
specimen at the level of the vesical neck (7,8,9). De-
spite highly elevated rates of maintenance of sexual
and urinary function observed with these techniques,
they presented, as a common feature, the risk of vio-
lating the bladder tumor and producing positive dis-
tal margins, when the neoplasia reaches the vesical
neck. This risk was reduced by Colombo et al. (9)
and by Vallancien et al. (8) who performed the endo-
scopic resection of the vesical neck and the prostate
previously, but even then, the potential risk of violat-
ing the neoplasia persists when the vesical neck is
sectioned transversely. In our technique, this possi-
bility is minimized due to the block removal of pros-
tatic parenchyma, vesical neck and bladder.
Another advantage of this cysto-
adenomectomy technique in relation to other pub-
lished approaches is that it implies in removing the
specimen in one stage. Both previous endoscopic re-
section (9) and that performed at the moment of cys-
tectomy (8) increase the length and morbidity of the
intervention.
If the ongoing study by our group confirms
better preservation of urinary continence and a lower
incidence of post-operative sexual dysfunction, this
technique may become a preferential method for per-
forming radical cystectomy in men with invasive blad-
der cancer. In such cases, the method could be em-
ployed every time that the presence of a primary pros-
tate cancer is previously ruled out, and when there is
no extensive secondary involvement of the prostate
gland from the vesical neoplasia.
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Srougi et al. adapted a few technical
maneuvers acquired from years of performing radical
and simple prostatectomies and applied them to a
cystoprostatectomy with orthotopic neobladder. The
objective is to preserve sexual function and improve
urinary continence. In my experience patients have
excellent daytime continence (< 5% wear pads)
although 15% empty by intermittent catheterization.
Nighttime incontinence is infrequent since most of
my patients wake up at least once per night. I have
elected to taper the ileum at the site of the urethral
anastomosis which may add to the functional urethral
length. I am not certain how important this is.
The issue of preserving erectile function is
an important one for a relatively small subset of men
who have a cystoprostatectomy and neobladder. The
percentage of men who are candidates for this prostate
capsule sparing is relatively low among all of the men
I evaluate for surgery. The majority of men is older
or has advanced local disease and thus they are
impotent or the extent of disease makes invasion of
the prostate a concern. I believe the patient must be
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one who understands the need for subsequent careful
monitoring - not only for urothelial cancer but for
adenocarcinoma of the prostate.
The men who are most likely to benefit from
these modifications of the standard cystoprostatectomy
are younger men who have recurrent or persistent high
grade Ta, CIS, or T1 bladder cancer and have failed
intravesical therapy. Once tumor at the bladder neck
(?) and prostatic urethra is excluded they might be
reasonable candidates for this approach.
There are some trade-offs when comparing
the standard procedure in which the entire prostate
and seminal vesicles are removed with Srougi’s
modification which leaves the prostate capsule and
seminal vesicles. This is not much different however,
from leaving the neurovascular bundles, bladder
neck, and the distal seminal vesicles during a radical
prostatectomy with the desire to improve the chance
of retaining normal pre-op erectile function. Each
case must be carefully judged based on pre and
intraoperative findings as well as a variety of patient
issues such as age and erectile function before
surgery.
Mark S. Soloway
Chairman, Department of Urology
University of Miami School of Medicine
Miami, Florida, USA
EDITORIAL COMMENT
En bloc removal of the bladder, prostate,
ampullae of the vasa deferentia and seminal vesicles
is now the paradigm treatment for muscle invasive
and recurrent high grade urothelial carcinomas.
However, largely due to significant associated
morbidities and only modest cure rates when applied
as a monotherapy, initial acceptance of this procedure
was not broad. Over the past 30-years both medical
and urologic oncologists have made dramatic strides
to improve the adverse consequences of effectively
treating urothelial cancer. Medical oncologists have
graduated patients from non-effective, single-agent
chemotherapy to the latest less-toxic but efficacious
combination of paclitaxel, carboplatin and
gemcitabine. With improved survival, urologic
oncologists have modified their surgical execution to
reduce morbidity and improve the social, sexual and
psychological implications of radical cystectomy.
Lower urinary tract reconstruction has evolved from
simple cutaneous ureterostomies and ileal conduits
to continent cutaneous urinary reservoirs, and most
recently the continent orthotopic neobladders. Today
men and women can safely undergo orthotopic lower
urinary tract reconstruction to the intact native urethra
while preserving the erectile nerve bundles and
importantly, the pelvic plexus supplying these nerve
bundles. This has given witness to a dramatic
improvements in both the longevity and quality of
our patients’ lives.
For continuing these forward strides in
surgical techniques with their described method, a
modification of that previously described by the USC
group (authors’ reference 6), the authors are to be
commended. And we are sure that many innovative
surgeons will continue to refine this technique to
provide even better outcomes for the patient of
tomorrow.
But in this search for minimal morbidity, let’s
not forget in whom and for what reason the vast
majority of radical cystectomies are performed. Today
the average male patient requiring cystectomy for
bladder cancer is in his sixth decade of life when the
reproductive necessity of preserving ejaculatory
function has generally long since past. In the end, this
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is the one morbidity of standard nerve sparing radical
cystoprostatectomy that we see as preserved through
this technique, and this is accomplished with a
questionable overall improvement in life’s quality for
the vast majority of men with urothelial carcinoma.
We are further puzzled as to the mechanism of
antegrade ejaculation following the removal of a
functional bladder neck and the necessity for its
coordinated closure to provide antegrade emission of
deposited seminal fluids.
With a very conscious recognition of the
anatomic location of the pelvic plexus lateral to the
seminal vesicles and its nervous supply to the erectile
nerve bundle as depicted in authors’ Figure-1,
maintaining the erectile nerve bundles should be no
more difficult during radical cystoprostatectomy than
radical prostatectomy. We commonly perform
retrograde release of the nerve bundles from apex to
base during radical cystoprostatectomy as we perform
it during radical prostatectomy. Similar to the reports
of others, this approach has allowed us to preserve
erectile function at rates similar to that seen following
isolated radical prostatectomy (1). While this
approach obviates ejaculatory function, is this truly
an issue for the majority of patients undergoing radical
cystoprostatectomy?
We then re-focus on the patients in whom the
majority of these surgeries are performed; sixty-year-
old men, who also have the highest incidence of
prostate cancer (2). Furthermore, we now recognize
that a significant number of prostate cancers exist in
men with serum PSA below 3ng/ml, the majority of
which are clinically significant (3,4). The benefits of
a radical cystectomy which preserves the posterior
lateral zones of the prostate might quickly fade for
the patient and physician alike when the serum PSA
starts rising and there is limited hope of performing
completion prostatectomy and reconstruction of the
orthotopic neobladder.
The authors’ approach is certainly appealing
when ejaculatory preservation is a quality of life issue.
We however caution that this select patient is few
and far between. For the young (20 to 30 year-old)
male with benign bladder disease necessitating
cystectomy (refractory cystitis glandularis) or non-
urothelial carcinoma away from the bladder neck in
whom fertility is an issue, this technique, offering
ejaculatory preservation, even if ejaculation is
retrograde into the neobladder where it can be
harvested, is alluring. For all others we feel there is
little benefit to be gained by this technique over a
properly performed nerve sparing cystoprostatectomy
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EDITORIAL COMMENT
The concept of preservation of the prostate at
the time of cystectomy for bladder cancer is not new
and has been applied sporadically since early in the
twentieth century. I first preserved the prostate capsule
in 1985 using a technique somewhat similar to Srougi
and subsequently in several carefully selected patients.
I have been reluctant to publish these cases due to the
uncertainty as to whether this technique will be viable
in the long term. Clearly, interest in this technique has
escalated with this recent report and the larger series of
Vallancien et al. from France (1).
While there are some early signs that this
technique may be beneficial for some patients, the
benefits versus the risks of the technique must be
addressed before its widespread use. The benefits
include probable decrease in blood loss, probable
improved continence, and probable improved erectile
function recovery. I emphasize the “probable” aspect
because the degree of improvement is certainly
unquantified, despite the initial observations of Srougi
and my experience as well. A validated Quality of
Life instrument suitable to quantify erectile function
and incontinence after a cystectomy and neobladder
surgery is not currently available; thus the magnitude
of improvement from this technique will be debatable
until studied in an appropriate fashion.
The risks are also unquantified. Using whole-
mount step-sectioning of the prostate, it has been
determined that approximately 40% of bladder cancer
cystectomy patients may harbor unsuspected
urothelial carcinoma in situ in the prostatic urethra
or prostatic ducts (2,3). Similarly, 40% to 50% of
patients have unsuspected adenocarcinoma of the
prostate (most of which are small and of uncertain
clinical significance) (3). Since the patient populations
with urothelial and adenocarcinomas do not
necessarily overlap, 40% to 80% of patients might
have a neoplasm in the prostate which may make it
unwise to leave the prostate capsule behind. Much of
this risk may be obviated by careful patient selection
and presurgical screening for prostate cancers as
suggested by Srougi, and a frozen section of the
adenomatous tissue removed from the prostate. If the
frozen section reveals either urothelial or
adenocarcinoma at the time of surgery, the prostate
capsule and seminal vesicle could be removed. If the
frozen section is benign, the neobladder could be sewn
to the prostate capsule as described in Srougi’s report.
As with many procedures in oncology, the
evolution is towards smaller, less extensive operations
that still reliably eliminate the cancer but preserve
better function (e.g., lumpectomy and radiation for
breast cancer or nerve-sparing radical prostatectomy).
Maybe it is time for a more critical study of a tailored
radical cystectomy for urothelial cancer. Careful
patient selection will unquestionably be the most
important aspect.
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